Frankfurt
04.08.26 | 08:02
0,000 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,009 | 0,035 | 09:49 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | KDventures AB: KDventures' portfolio company Umecrine Cognition enrolls last patient in ongoing Phase 1b/2a study | 83 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, August 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that its portfolio company Umecrine Cognition has enrolled the last patient in the ongoing Phase 1b/2a study... ► Artikel lesen | |
| 12.05. | KDventures AB: KDventures' Annual General Meeting 2026 | 233 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - May 12, 2026. KDventures AB (publ) ("KDventures" or the "Company") held the Annual General Meeting on May 12, 2026. The shareholders have had the right to exercise their voting rights... ► Artikel lesen | |
| 30.04. | KDventures AB: Interim Report - January-March 2026 | 228 | GlobeNewswire (Europe) | STOCKHOLM - 30 April 2026. KDventures AB (Nasdaq Stockholm: KDV) today publishes its Interim Report January-March 2026. The full report is available on the Company's website.
"We started 2026 by strengthening... ► Artikel lesen | |
| 09.04. | KDventures AB: KDventures' portfolio company SVF Vaccines partners with Touchlight to accelerate SVF-001 toward clinical development | 206 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, April 9, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that its portfolio company SVF Vaccines has entered into a collaboration with Touchlight, a biotechnology company... ► Artikel lesen | |
| 11.03. | KDventures AB: KDventures' portfolio company AnaCardio extends IP protection for AC01 until the 2040s with new US patent approval | 239 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN March 11, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that its portfolio company AnaCardio has received approval for a US patent covering the use of AC01 for the treatment... ► Artikel lesen | |
| KDVENTURES Aktie jetzt für 0€ handeln | |||||
| 03.03. | KDventures AB: KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos' drug candidate for PCOS | 433 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, March 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that Organon has discontinued the development of a preclinical drug candidate for polycystic ovarian syndrome... ► Artikel lesen | |
| 27.02. | Change of number of shares and votes in KDventures AB | 1 | GlobeNewswire (USA) | ||
| 24.02. | KDventures AB: KDventures's portfolio company SVF Vaccines announces that the intended merger with Novakand Pharma will not be carried out following negative decision from Nasdaq | 440 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, February 24, 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that the planned reversed acquisition of the portfolio company SVF Vaccines by Novakand Pharma will not be completed... ► Artikel lesen | |
| 13.02. | KDventures AB: Year-end Report - January-December 2025 | 305 | GlobeNewswire (Europe) | STOCKHOLM - 13 February 2025. KDventures AB (Nasdaq Stockholm: KDV) today publishes its Year-end Report January-December 2025. The full report is available on the Company's website. "A stronger financial... ► Artikel lesen | |
| 12.02. | KDventures AB (publ): KDventures AB (publ) carries out a directed issue of shares to guarantors in connection with the completed rights issue | 338 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 10.02. | KDventures AB (publ): KDventures' portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer | 367 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 10 February 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that its portfolio company SVF Vaccines has appointed Raheleh Nassaji as Chief Executive Officer to lead the transition... ► Artikel lesen | |
| 09.02. | Change of issuer name and symbol for Karolinska Development AB | 400 | GlobeNewswire | As from February 10, 2026, Karolinska Development AB will change issuer name and symbol.
Old issuer name: Karolinska Development AB
New issuer name: KDventures AB
Old symbol: KDEV
New symbol: KDV
ISIN... ► Artikel lesen | |
| 06.02. | Karolinska Development AB (publ): Karolinska Development's portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement | 319 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, February 6, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has entered into a reverse acquisition agreement with Novakand... ► Artikel lesen | |
| 28.01. | Karolinska Development AB: Karolinska Development AB (publ) announces the outcome of the rights issue and change of the company name to KDventures AB | 430 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 23.01. | Karolinska Development AB (publ): Karolinska Development AB receives additional guarantee commitments in ongoing rights issue | 672 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 21.01. | Karolinska Development AB (publ): Karolinska Development's portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin | 299 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - January 21, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has signed a binding term sheet with Exeltis, a global Women's... ► Artikel lesen | |
| 12.01. | Listing of subscription rights and paid subscription shares of Karolinska Development AB | 397 | GlobeNewswire | With effect from January 13, 2026, the subscription rights of Karolinska Development AB will be traded on the list for Equity rights. Trading will continue up until and including January 22, 2026.
... ► Artikel lesen | |
| 09.01. | Karolinska Development AB (publ) announces publication of information document in connection with upcoming rights issue | 329 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 08.01. | Karolinska Development AB (publ): Karolinska Development's Extraordinary General Meeting 2026 | 453 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - January 8, 2026. Karolinska Development AB (publ) ("Karolinska Development" or the "Company") held an Extraordinary General Meeting on January 8, 2026, at which the shareholders... ► Artikel lesen | |
| 07.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.01.2026 | 821 | Xetra Newsboard | Das Instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON EQUITY wird cum Kapitalmassnahme gehandelt am 07.01.2026 und ex Kapitalmassnahme am 08.01.2026 The instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON... ► Artikel lesen |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NAKIKI | 0,190 | +8,88 % | Nakiki SE: Wirtschaftsprüfer versagt für 2024 das Testat | Der Abschlussprüfer der Nakiki SE hat dem Jahresabschluss und Lagebericht für das Rumpfgeschäftsjahr vom 3. April bis 31. Dezember 2024 das Testat versagt. Grund ist nach Angaben der Gesellschaft, dass... ► Artikel lesen | |
| ISHARES BITCOIN TRUST | 36,150 | -0,03 % | Fed-Showdown: Bitcoin und Ethereum erholen sich vor Zinsentscheid | © Foto: Dall-EDer Kryptomarkt blickt auf den Zinsentscheid der Fed. Im Vorfeld notieren Bitcoin, Ethereum und die meisten der größten Kryptowährungen im grünen Bereich.Bitcoin und Ethereum haben sich... ► Artikel lesen | |
| DIREXION DAILY S&P 500 BULL 3X | 279,71 | +0,02 % | Direxion Daily S&P 500 Bull 3X Shares declares quarterly distribution of $0.5231 | ||
| BLUE OWL CAPITAL | 11,150 | 0,00 % | Blue Owl Capital: Warum die Luft beim Bewertungsmultiplikator dünner wird | Blue Owl Capital steht nach einer starken Kursentwicklung an einem Wendepunkt: Die Aufwärtsperspektiven für ein weiteres Multiple-Expansion gelten als begrenzt, während das operative Wachstum intakt... ► Artikel lesen | |
| REAL ESTATE SELECT SECTOR SPDR FUND | 45,175 | 0,00 % | XLRE reaches 52-week high after upbeat housing data; here are its top holdings | ||
| PROSHARES ULTRA QQQ | 86,57 | -0,06 % | $1000 Invested In ProShares Ultra QQQ 10 Years Ago Would Be Worth This Much Today | ||
| PAGAYA TECHNOLOGIES | 22,220 | -0,07 % | Pagaya Technologies advances 9%, adding to last week's post-earnings rally | ||
| CHIME FINANCIAL | 24,260 | 0,00 % | Chime streicht nach KI-Effizienzgewinnen 10 % der Stellen | ||
| FIDELITY WISE ORIGIN BITCOIN FUND | 55,55 | 0,00 % | Der FBTC von Fidelity führt nach zehn Tagen mit Abflüssen eine Erholung der Bitcoin-ETFs im Wert von 222 Millionen Dollar an | ||
| DIREXION DAILY SMALL CAP BULL 3X | 70,99 | 0,00 % | Direxion Daily Small Cap Bull 3X Shares declares quarterly distribution of $0.0875 | ||
| PROSHARES SHORT QQQ | 26,365 | -0,02 % | $10,000 in each of QQQ, TQQQ, and SQQQ 5 years ago: Here's the result | ||
| ALLIANZ | 434,10 | +0,28 % | EQS-CMS: Allianz SE: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Allianz SE
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014 und Art. 2 Abs. 3 der Delegierten Verordnung (EU) Nr.... ► Artikel lesen | |
| ROCKET COMPANIES | 13,680 | 0,00 % | Rocket Cos Aktie: Optionsmarkt erwartet 6,7 % Kursbewegung nach Quartalszahlen am 6. August | ||
| IONIC DIGITAL | 69,50 | +0,67 % | Neptune Digital Assets Corp: Neptune Announces Monetization of Its Ionic Digital Holdings | Vancouver, British Columbia--(Newsfile Corp. - July 29, 2026) - Neptune Digital Assets Corp. (TSXV: NDA) (OTCQB: NPPTF) (FSE: 1NW) ("Neptune" or the "Company"), a blockchain infrastructure and frontier... ► Artikel lesen | |
| NATWEST GROUP | 8,400 | 0,00 % | AKTIE IM FOKUS: Natwest-Aktie steigt auf höchsten Stand seit 2008 | LONDON (dpa-AFX) - Die Aktie von Natwest ist am Freitag auf ihren höchsten Stand seit der Weltfinanzkrise 2008 gestiegen. Für die Papiere ging es zuletzt um 4,5 Prozent auf gut 714 Pence nach oben.... ► Artikel lesen |
Das Unternehmen KDVENTURES AB kann der Branche Finanzdienstleistungen zugeordnet werden. Der aktuelle Kurs liegt bei 0,000 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KDVENTURES AB finden Sie auf Wallstreet Online.